Your browser doesn't support javascript.
loading
The value of plasma metanephrine measurements during adrenal vein sampling.
Carroll, Richard W; Corley, Brian; Feltham, Joe; Whitfield, Patricia; Park, William; Howard, Rowena; Yssel, Melissa; Phillips, Ian; Harper, Simon; Yang, Jun.
Affiliation
  • Carroll RW; Endocrine, Diabetes, and Research Centre, Wellington Regional Hospital, New Zealand.
  • Corley B; Endocrine, Diabetes, and Research Centre, Wellington Regional Hospital, New Zealand.
  • Feltham J; Department of Medicine, University of Otago, Wellington, New Zealand.
  • Whitfield P; Department of Radiology, Wellington Regional Hospital, New Zealand.
  • Park W; Endocrine, Diabetes, and Research Centre, Wellington Regional Hospital, New Zealand.
  • Howard R; Department of Medicine, University of Otago, Wellington, New Zealand.
  • Yssel M; University of Otago, Wellington, New Zealand.
  • Phillips I; Diabetes and Endocrinology Service, Hutt Hospital, New Zealand.
  • Harper S; Department of Biochemistry & Endocrinology, Awanui Labs, New Zealand.
  • Yang J; Department of Biochemistry, Awanui Labs, Dunedin, New Zealand.
Endocr Connect ; 13(2)2024 Feb 01.
Article de En | MEDLINE | ID: mdl-38055778
ABSTRACT

Objective:

The assessment of primary aldosteronism incorporates adrenal vein sampling (AVS) to lateralize aldosterone excess. Current adrenal vein sampling protocols rely on concurrent cortisol measurements to assess successful cannulation and lateralization and may be inaccurate in the setting of autonomous cortisol secretion. We aimed to compare the measurement of plasma cortisol and metanephrine concentrations to assess cannulation and lateralization during AVS.

Design:

This is a diagnostic accuracy study in a tertiary referral endocrinology department.

Methods:

Forty-one consecutive patients with confirmed primary aldosteronism undergoing AVS (49 procedures) were included. None had cortisol autonomy. The use of plasma metanephrine-based ratios were compared with standard cortisol-based ratios to assess cannulation and lateralization during ACTH-stimulated AVS.

Results:

There was strong agreement between a cortisol selectivity index (SI) ≥5.0 and an adrenal vein (AV) to peripheral vein (PV) plasma metanephrine ratio (AVmet-PVmet) of ≥12.0 to indicate successful cannulation of the AV (n = 117, sensitivity 98%, specificity 89%, positive predictive value (PPV) 95%, negative predictive value (NPV) 94%). There was strong agreement between the standard cortisol-based SI and an AV plasma metanephrine-to-normetanephrine ratio (AVmet-AVnormet) of ≥2.0 to indicate successful cannulation (n = 117, sensitivity 93%, specificity 86%, PPV 94%, NPV 84%). There was strong agreement between the cortisol- or metanephrine-derived lateralization index (LI) > 4.0 for determining lateralization (n = 26, sensitivity 100%, specificity 94.1%, PPV 91.6%, NPV 100%).

Conclusions:

Ratios incorporating plasma metanephrines provide comparable outcomes to standard cortisol-based measurements for interpretation of AVS. Further studies are required to assess the use of metanephrine-derived ratios in the context of confirmed cortisol autonomy. Significance statement Primary aldosteronism is a common cause of secondary hypertension, and adrenal vein sampling remains the gold standard test to assess lateralization. Cortisol-derived ratios to assess cannulation and lateralization may be affected by concurrent cortisol dysfunction, which is not uncommon in the context of primary aldosteronism. Our study showed comparable outcomes when using accepted cortisol-derived or metanephrine-derived ratios to determine cannulation and lateralization during adrenal vein sampling. Further research is required to validate these findings and to assess the use of metanephrine-derived ratios in the context of confirmed concurrent cortisol dysfunction.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Endocr Connect Année: 2024 Type de document: Article Pays d'affiliation: Nouvelle-Zélande Pays de publication: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Endocr Connect Année: 2024 Type de document: Article Pays d'affiliation: Nouvelle-Zélande Pays de publication: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM